Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 16, 2022

BUY
$94.08 - $130.2 $46,381 - $64,188
493 New
493 $252,000
Q4 2021

Feb 15, 2022

SELL
$129.87 - $162.82 $259,740 - $325,640
-2,000 Closed
0 $0
Q3 2021

Nov 16, 2021

BUY
$106.71 - $143.18 $213,420 - $286,360
2,000 New
2,000 $1.09 Million

Others Institutions Holding DXCM

About DEXCOM INC


  • Ticker DXCM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 386,257,984
  • Market Cap $30.1B
  • Description
  • DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...
More about DXCM
Track This Portfolio

Track Iii Capital Management Portfolio

Follow Iii Capital Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Iii Capital Management, based on Form 13F filings with the SEC.

News

Stay updated on Iii Capital Management with notifications on news.